Physician profile
Vamsi Krishna
NPI 1891930863
$1,963,531.70
in general payments reported to CMS, 2019-2025
63 companies · $263K in 2025
The $263K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $238K · 2020: $253K · 2021: $326K · 2022: $275K · 2023: $262K · 2024: $346K · 2025: $263K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $389K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $227K · Consulting Fee: $121K · Travel and Lodging: $73K · Food and Beverage: $46K · Honoraria: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $388,902.37 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $226,950.00 |
| Consulting Fee | $120,775.00 |
| Travel and Lodging | $72,646.27 |
| Food and Beverage | $46,254.16 |
| Honoraria | $15,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $518,297.22 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $425,617.51 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $195,461.94 | 2019-2025 | Dragonfly Opstar, Ultreon, Coroflow |
| Novo Nordisk INC | $144,702.41 | 2022-2025 | Ozempic, Rybelsus |
| Amgen INC. | $107,289.13 | 2019-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $94,489.03 | 2019-2022 | |
| Lilly USA, LLC | $77,366.03 | 2025 | Zepbound, Mounjaro |
| Scpharmaceuticals INC. | $67,248.38 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $50,772.07 | 2019-2025 | Farxiga, Brilinta, Lokelma |
| Medtronic, INC. | $49,331.38 | 2021-2025 | Abre, In.Pact Admiral, Symplicity G3 |
| Cook Incorporated | $38,079.88 | 2021-2024 | Zilver Vena, Advance |
| Cardiovascular Systems INC. | $29,639.36 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Philips North America LLC | $26,325.96 | 2019-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided, (Dd1) Duo Hybrid |
| Inari Medical, INC. | $25,729.33 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Atricure, INC. | $22,542.04 | 2020-2023 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $15,350.11 | 2019-2020 | |
| Cardinal Health 200 LLC | $14,765.92 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $10,561.38 | 2020-2024 | Naeotom Alpha, Artis Icono Floor |
| Acist Medical Systems, INC. | $10,146.44 | 2021-2024 | |
| Heartflow, INC. | $8,741.83 | 2019-2025 | |
| Biotronik INC. | $5,701.67 | 2019-2025 | Orsiro Mission, Recross, Nhancer Rx |
| Cook Medical LLC | $5,036.63 | 2019-2025 | Zilver Ptx, Advance, Rosen |
| Boston Scientific Corporation | $3,388.67 | 2019-2025 | General - Vascular Intervention, Enroute Transcarotid Neuroprotection System, Watchman |
| Bayer Healthcare Pharmaceuticals INC. | $2,964.09 | 2022 | |
| Reflow Medical INC | $2,408.92 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $1,726.19 | 2019-2025 | |
| Janssen Research & Development, LLC | $1,194.23 | 2023 | |
| Penumbra, INC. | $893.97 | 2019-2025 | Indigo System, Penumbra System |
| Abiomed | $722.16 | 2019-2023 | Impella |
| Corindus INC. | $680.36 | 2019 | |
| Teleflex LLC | $586.12 | 2025 | Orsiro Mission, Manta, Pantera Leo |
| Bard Peripheral Vascular, INC. | $573.55 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Biosense Webster, INC. | $554.49 | 2022-2025 | Carto 3 |
| Amarin Pharma, INC. | $465.54 | 2019-2022 | |
| Tactile Systems Technology INC | $406.27 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Irhythm Technologies, INC. | $378.23 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $358.87 | 2022-2023 | Optimizer |
| Esperion Therapeutics, INC. | $285.49 | 2020-2023 | Nexletol |
| Recor Medical INC | $239.36 | 2024 | Paradise Renal Denervation System |
| Haemonetics Corporation | $237.42 | 2019-2021 | |
| Avinger INC. | $227.27 | 2022-2023 | Pantheris |
| Surmodics, INC. | $222.70 | 2022-2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Ekos Corporation | $218.05 | 2019 | |
| Osprey Medical INC | $206.38 | 2021 | |
| Baylis Medical Technologies INC. | $200.09 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.08 | 2019-2024 | Lifevest |
| Cordis US Corp. | $159.32 | 2021 | |
| W. L. Gore & Associates, INC. | $158.49 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $140.72 | 2025 | Camzyos, Eliquis |
| Stryker Corporation | $95.41 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Revcore Thrombectomy Catheter |
| Z-Medica, LLC | $82.56 | 2020 | |
| Angiodynamics, INC. | $57.35 | 2024 | Alphavac |
| Veryan Medical Incorporated | $47.42 | 2021 | |
| Cvrx, INC. | $47.31 | 2021 | |
| Foundation Fusion Solutions, LLC | $47.06 | 2022 | |
| Becton, Dickinson and Company | $42.04 | 2024 | Rotarexs 6 F X 135 Cm |
| Edwards Lifesciences Corporation | $39.22 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $35.53 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $32.92 | 2025 | Assure Wcd |
| Pfizer INC. | $15.98 | 2024 | |
| Mannkind Corporation | $14.75 | 2025 | |
| Sanofi-Aventis U.S. LLC | $12.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$10,387.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vamsi Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.